Concepedia

John R. Wetterau

JR

Statistics

Publications

40

Citations

6.7K

H-Index

36

Active since

1982

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Sweden)

University of Cincinnati Medical Center

University of Cincinnati

Bristol-Myers Squibb (Germany)

John R. Wetterau is an author at Bristol-Myers Squibb (United States) specializing in life sciences, biochemistry, and lipid metabolism.

Publications per year

1982–2008

40

Publications

40

Absence of Microsomal Triglyceride Transfer Protein in Individuals with Abetalipoproteinemia

John R. Wetterau, Lawrence P. Aggerbeck, Marie-Elisabeth Bouma et al. · Science · 1992 · 759 citations

, , +14

Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes

Wei Meng, Bruce A. Ellsworth, Alexandra A. Nirschl et al. · Journal of Medicinal Chemistry · 2008 · 628 citations · Full text

, , +17

Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia

Daru Sharp, Laura Blinderman, Kelly A. Combs et al. · Nature · 1993 · 503 citations

, , +14

Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats

Song‐Ping Han, Deborah Hagan, Joseph R. Taylor et al. · Diabetes · 2008 · 418 citations · Full text

, , +16

Protein disulfide isomerase is a component of the microsomal triglyceride transfer protein complex.

John R. Wetterau, K A Combs, Sara N. Spinner et al. · Journal of Biological Chemistry · 1990 · 367 citations · Full text

, , +15

1–5 of 40